NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
VHA Deploys Agentic AI Operating System to Improve Care Delivery
The new agentic AI system connects teams, automates workflows and accelerates decision-making across VA medical centers.
4m read -
Inside DOE’s Genesis Mission to Power AI-Driven Science
Rick Stevens explains how DOE’s Genesis mission is integrating supercomputing, AI and quantum technologies to accelerate scientific discovery.
25m watch -
NOAA Improves Geospatial Accuracy With NSRS Modernization
NOAA is integrating GPS and new gravity data to improve accuracy of its National Spatial Reference System.
9m listen -
How to Help Tech Cross the Valley of Death
Leslie Beavers discussed down how her firm, LB Insights, guides firms toward delivering capabilities aligned with DOW modernization goals.
10m watch
